Products like ‘Repatha Inj’ & ‘Soolantra Cream 1%’ enter Asan Medical Center

Published: 2018-02-27 16:27:00
Updated: 2018-02-27 16:26:11

Amgen’s ‘Repatha Inj’ and Galderma’s ‘Soolantra Cream 1%’ entered Asan Medical Center.

At the 142nd Drug Committee, Asan Medical Center approved introduction of ‘Repatha Inj,’ the Amgen Korea’s PCSK9-inhibiting cholesterol treatment, and ‘Soolantra Cream 1%,’ the Galderma Korea’s local inflammat...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.